16-11553578-G-C

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PM5PP5_Very_Strong

The NM_001136472.2(LITAF):​c.332C>G​(p.Ala111Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A111T) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

LITAF
NM_001136472.2 missense

Scores

2
14
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3U:1O:1

Conservation

PhyloP100: 7.18

Publications

4 publications found
Variant links:
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
LITAF Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 1C
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_001136472.2
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-11553579-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 639258.We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
PP5
Variant 16-11553578-G-C is Pathogenic according to our data. Variant chr16-11553578-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 41229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LITAFNM_001136472.2 linkc.332C>G p.Ala111Gly missense_variant Exon 3 of 4 ENST00000622633.5 NP_001129944.1 Q99732-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LITAFENST00000622633.5 linkc.332C>G p.Ala111Gly missense_variant Exon 3 of 4 1 NM_001136472.2 ENSP00000483114.1 Q99732-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3Uncertain:1Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 1C Pathogenic:2Other:1
Jul 12, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: LITAF c.332C>G (p.Ala111Gly) results in a non-conservative amino acid change located in the LPS-induced tumour necrosis factor alpha factor domain (IPR006629) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251206 control chromosomes. c.332C>G has been reported in the literature in multiple individuals affected with Charcot-Marie Disease Type 1C and segregated with disease in at least one family (e.g. Latour_2006). These data indicate that the variant is very likely to be associated with disease. Experimental in vitro studies show that this variant causes mislocalization (e.g. Zhu_2013, Lacerda_2014). The following publications have been ascertained in the context of this evaluation (PMID: 25058650, 16787513, 23576546). ClinVar contains an entry for this variant (Variation ID: 41229). Based on the evidence outlined above, the variant was classified as pathogenic. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 14, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects LITAF function (PMID: 23576546, 25058650). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 41229). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 16787513, 32376792). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 111 of the LITAF protein (p.Ala111Gly). -

Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Inherited Neuropathy Consortium
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.17
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D;D;.;D;.;D;.;D;D;D;.;.;.;.
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.84
.;T;.;.;D;.;D;.;.;D;D;D;D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Uncertain
0.73
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.72
D
MutationAssessor
Uncertain
2.5
M;M;M;M;M;M;.;M;M;.;.;M;.;.
PhyloP100
7.2
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.8
.;.;N;N;N;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.55
Sift
Uncertain
0.025
.;.;D;T;D;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.035
D;D;T;D;T;D;T;D;D;.;.;T;.;T
Polyphen
0.83
P;P;.;P;.;P;.;P;P;.;.;.;.;.
Vest4
0.56
MutPred
0.41
Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);.;Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);
MVP
1.0
MPC
0.35
ClinPred
0.96
D
GERP RS
5.4
Varity_R
0.34
gMVP
0.47
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs281865134; hg19: chr16-11647434; API